Showing 1,161 - 1,180 results of 5,371 for search '"Virus"', query time: 0.09s Refine Results
  1. 1161

    CD4 T cell dynamics shape the immune response to combination oncolytic herpes virus and BRAF inhibitor therapy for melanoma by Victoria Jennings, Kevin Harrington, Hardev Pandha, Alan Melcher, Adel Samson, Fiona Errington-Mais, Victoria Roulstone, Eva Crespo-Rodriguez, Galabina Bozhanova, Shane Foo, Emmanuel C Patin, Martin McLaughlin, Malin Pedersen, Richard Vile, Joan Kyula, Jehanne Hassan, Lizzie Appleton, Charleen ML Chan Wah Hak, Gabby Baker, Edward Armstrong, Matthew Chiu, Masahiro Ono

    Published 2022-03-01
    “…Background Combination herpes simplex virus (HSV) oncolytic virotherapy and BRAF inhibitors (BRAFi) represent promising immunogenic treatments for BRAF mutant melanoma, but an improved understanding of the immunobiology of combinations is needed to improve on the benefit of immune checkpoint inhibitors (ICI).Methods Using a BRAFV600E-driven murine melanoma model, we tested the immunogenicity of HSV/BRAFi in immunocompetent C57BL mice. …”
    Get full text
    Article
  2. 1162

    Identifying Safeguards Disabled by Epstein-Barr Virus Infections in Genomes From Patients With Breast Cancer: Chromosomal Bioinformatics Analysis by Bernard Friedenson

    Published 2025-01-01
    “…A potential risk factor is Epstein-Barr virus (EBV), a lifelong infection nearly everyone acquires. …”
    Get full text
    Article
  3. 1163
  4. 1164

    Investigation of persistant bovine viral diarrhea virus (bvdv) infection at the pregnant cows and their calves bv immunoflourescence and immunperoxidase tests by Orhan Yapkıç, Sibel Yavru

    “…Direct immunoflourescence (DIF) and direct immunperoxidase (DPLA) tests were used for virus isolation from leucocyte samples, serum neutralisation test was used to detect antibodies against BVDV. …”
    Get full text
    Article
  5. 1165
  6. 1166

    Factores de riesgo para hepatocarcinoma en pacientes con fibrosis avanzada o cirrosis por virus C by Yusimik Roman Martinez, Rosmy Fabiola Aguilar Aguilar, Marlén Castellanos Fernández, Sila María González Suero, Rebeca Winograd Lay, Mirtha Infante Velázquez

    Published 2024-06-01
    “…Introducción: La eliminación del virus de la hepatitis C con el tratamiento antiviral no excluye el riesgo de carcinoma hepatocelular en pacientes con fibrosis avanzada/cirrosis. …”
    Get full text
    Article
  7. 1167
  8. 1168
  9. 1169
  10. 1170
  11. 1171
  12. 1172
  13. 1173

    Exploring the antiviral potential of shikimic acid against Chikungunya virus through network pharmacology, molecular docking, and in vitro experiments by Jialiang Xin, Xingxing Song, Haohong Zheng, Wenjing Li, Yuyang Qin, Wei Wang, Wei Wang, He Zhang, Guangneng Peng

    Published 2025-01-01
    “…Chikungunya virus (CHIKV) is an arbovirus that can lead to chronic arthritis and significantly diminish the quality of life of patients. …”
    Get full text
    Article
  14. 1174

    The Burden of Hepatitis C Virus Infection Is Growing: A Canadian Population-Based Study of Hospitalizations from 1994 to 2004 by Robert P Myers, MingFu Liu, Abdel Aziz M Shaheen

    Published 2008-01-01
    “…BACKGROUND: Nearly 1% of Canadians are infected with the hepatitis C virus (HCV). Simulation analyses have suggested that HCV will place an increasing burden on the health care system as the infected population ages, but supportive clinical data are limited.…”
    Get full text
    Article
  15. 1175

    Five-Year Prospective Follow-Up of Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antiviral Agents by Zhang Y, Xia H, Fan L, Jiang L, Yang B, Wang F

    Published 2025-01-01
    “…Yaping Zhang,1,2,* Huan Xia,3,* Luchang Fan,1 Lu Jiang,4 Bin Yang,2 Fengmei Wang4,5 1The Third Central Clinical College of Tianjin Medical University, Tianjin Medical University, Tianjin, 300170, People’s Republic of China; 2Tianjin Key Laboratory of Extracorporeal Life Support for Critical Diseases, Institute of Hepatobiliary Disease, Nankai University Affiliated Third Central Hospital, Tianjin, 300072, People’s Republic of China; 3Department of Infectious Diseases, Tianjin Second People’s Hospital, Tianjin, 300192, People’s Republic of China; 4Department of Hepatology and Gastroenterology, Tianjin First Central Hospital, Tianjin, 300192, People’s Republic of China; 5Tianjin Key Laboratory of Molecular Diagnosis and Treatment of Liver Cancer, Tianjin First Central Hospitial, Tianjin, 300192, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fengmei Wang; Bin Yang, Email wangfengmeitj@126.com; bioyang@126.comPurpose: The research intended to present prospective data on the long-term prognosis of individuals with hepatitis C virus (HCV) infection who received direct-acting antiviral agent (DAA) treatment.Patients and Methods: Patients who received DAA treatment at Tianjin Third Central Hospital and Tianjin Second People’s Hospital were prospectively enrolled and subsequently underwent a longitudinal follow-up. …”
    Get full text
    Article
  16. 1176

    Evolución de la Enfermedad por el virus del Chikungunya en pacientes con Lupus Eritematoso Sistémico by Nicolás González Velázquez, Fernando Gauto, Nelly Colman, Isabel Acosta

    Published 2023-12-01
    “…Introducción: La Enfermedad por el virus del Chikungunya (CHIKV) es una virosis que se caracteriza por fiebre acompañada de dolores articulares. …”
    Get full text
    Article
  17. 1177

    Molecular Detection and Determination of Phylogenetic Position of Watermelon Chlorotic Stunt Virus Khouzestan Isolate Based on Coat Protein Gene by Samira Pakbaz, Zahra Jelavi, Ehsan Hasanvand, Hossein Mirzaei Najafgholi

    Published 2024-02-01
    “…Watermelon chlorotic stunt virus (WmCSV) is a destructive Begomovirus from the family of Geminiviridae with a bipartite genome including similar-sized circular, single-stranded DNA (DNA-A and DNA-B) which has recently developed dangerously in many countries in the Middle East. …”
    Get full text
    Article
  18. 1178
  19. 1179

    Seropositivity for Bovine Viral Diarrhea and Enzootic Bovine Leukemia viruses in Blanco Orejinegro cattle in Colombia and infection associated-factors by A. Saldarriaga-Saldarriaga, M. Londoño-Gil, L. G. González-Herrera, J. C. Rincón-Flórez, A. López-Herrera

    Published 2021-01-01
    “…The aim of this study was to establish the serological status for Bovine Viral Diarrhea (BVD) and Enzootic Bovine Leukemia (EBL) viruses in Blanco Orejinegro (BON) cattle from Colombia, and to identify the factors associated with seropositivity. …”
    Get full text
    Article
  20. 1180